HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Liver transplantation using University of Wisconsin or Celsior preserving solutions in the portal vein and Euro-Collins in the aorta.

AbstractINTRODUCTION:
Orthotopic liver transplantation (OLT) is today the gold standard treatment of the end-stage liver disease. Different solutions are used for graft preservation. Our objective was to compare the results of cadaveric donor OLT, preserved with the University of Wisconsin (UW) or Celsior solutions in the portal vein and Euro-Collins in the aorta.
METHODS:
We evaluated retrospectively 72 OLT recipients, including 36 with UW solution (group UW) and 36 with Celsior (group CS). Donors were perfused in situ with 1000 mL UW or Celsior in the portal vein of and 3000 mL of Euro-Collins in the aortia and on the back table managed with 500 mL UW or Celsior in the portal vein, 250 mL in the hepatic artery, and 250 mL in the biliary duct. We evaluated the following variables: donor characteristics, recipient features, intraoperative details, reperfusion injury, and steatosis via a biopsy after reperfusion. We noted grafts with primary nonfunction (PNF), initial poor function (IPF), rejection episodes, biliary duct complications, hepatic artery complications, re-OLT, and recipient death in the first year after OLT.
RESULTS:
The average age was 33.6 years in the UW group versus 41 years in the CS group (P = .048). There was a longer duration of surgery in the UW group (P = .001). The other recipient characteristics, ischemia-reperfusion injury, steatosis, PNF, IPF, rejection, re-OLT, and recipient survival were not different. Stenosis of the biliary duct occured in 3 (8.3%) cases in the UW group and 8 (22.2%) in the CS (P = .19) with hepatic artery thrombosis in 4 (11.1%) CS versus none in the UW group (P = .11).
CONCLUSION:
Cadaveric donor OLT showed similar results with organs preserved with UW or Celsior in the portal vein and Euro-Collins in the aorta.
AuthorsW J Duca, R F da Silva, P C Arroyo Jr, A Sgnolf, C M Cabral, D C Ayres, H C C Felício, R D C M A da Silva
JournalTransplantation proceedings (Transplant Proc) Vol. 42 Issue 2 Pg. 429-34 (Mar 2010) ISSN: 1873-2623 [Electronic] United States
PMID20304157 (Publication Type: Journal Article)
CopyrightCopyright (c) 2010. Published by Elsevier Inc.
Chemical References
  • Celsior
  • Disaccharides
  • Electrolytes
  • Euro-Collins' solution
  • Glutamates
  • Hypertonic Solutions
  • Immunosuppressive Agents
  • Insulin
  • Organ Preservation Solutions
  • University of Wisconsin-lactobionate solution
  • Mannitol
  • Histidine
  • Allopurinol
  • Glutathione
  • Adenosine
  • Raffinose
Topics
  • Adenosine (therapeutic use)
  • Adolescent
  • Adult
  • Aged
  • Allopurinol (therapeutic use)
  • Aorta, Abdominal (drug effects, physiology)
  • Cadaver
  • Child
  • Child, Preschool
  • Disaccharides (therapeutic use)
  • Electrolytes (therapeutic use)
  • Female
  • Glutamates (therapeutic use)
  • Glutathione (therapeutic use)
  • Histidine (therapeutic use)
  • Humans
  • Hypertonic Solutions (therapeutic use)
  • Immunosuppressive Agents (therapeutic use)
  • Insulin (therapeutic use)
  • Liver Failure (surgery)
  • Liver Transplantation (immunology, methods)
  • Male
  • Mannitol (therapeutic use)
  • Middle Aged
  • Organ Preservation (methods)
  • Organ Preservation Solutions (therapeutic use)
  • Portal Vein (drug effects, physiology)
  • Postoperative Complications (epidemiology)
  • Prospective Studies
  • Raffinose (therapeutic use)
  • Reperfusion Injury (epidemiology)
  • Retrospective Studies
  • Tissue Donors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: